Tandem Diabetes Care (TNDM)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$19.90-2.59%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TNDM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 1,041.4 | 1,014.7 | 940.2 | 747.7 | 801.2 | 702.8 | 498.8 | 362.3 | 183.9 | 107.6 | 84.2 | 72.9 | 49.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 107.6 | 84.2 | 72.9 | 49.7 |
| Cost of Revenues | 458.1 | 468.7 | 450.6 | 380.0 | 388.2 | 326.6 | 238.3 | 168.1 | 94.0 | 63.5 | 60.7 | 46.3 | 34.5 |
| Gross Profit | 583.3 | 546.0 | 489.6 | 367.7 | 413.0 | 376.2 | 260.5 | 194.2 | 89.8 | 44.1 | 23.6 | 26.6 | 15.2 |
| Operating Expenses & Income | |||||||||||||
| Selling, General & Admin | 441.4 | 445.0 | 389.8 | 352.5 | 335.7 | 261.5 | 204.9 | 165.7 | 105.2 | 86.4 | 82.8 | 78.6 | 75.1 |
| R&D Expenses | — | — | — | — | — | 92.1 | 63.6 | 45.2 | 29.2 | 20.7 | 18.8 | 17.0 | 15.8 |
| Operating Income | (45.8) | (187.3) | (99.1) | (233.2) | (92.8) | 22.7 | (8.0) | (16.7) | (44.6) | (62.9) | (78.1) | (69.0) | (75.7) |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | 7.9 | 7.4 | — | — | — | — | — | — | — | — | — | — |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (61.0) | (200.3) | (91.9) | (220.3) | (92.9) | 15.9 | (36.3) | (24.6) | (122.6) | (73.0) | (83.5) | (72.4) | (79.5) |
| Income Tax Expense | 2.3 | 4.4 | 4.2 | 2.4 | 1.7 | 0.3 | (1.9) | 0.1 | 0.1 | 0.0 | (0.0) | 0.0 | 0.1 |
| Net Income | |||||||||||||
| Net Income | (63.3) | (204.7) | (96.0) | (222.6) | (94.6) | 15.6 | (34.4) | (24.8) | (122.6) | (73.0) | (83.4) | (72.4) | (79.5) |
| Per Share | |||||||||||||
| Basic EPS | (0.92) | (3.04) | (1.47) | (3.43) | (1.47) | 0.25 | (0.56) | — | — | — | — | — | — |
| Diluted EPS | (0.92) | (3.04) | (1.47) | (3.43) | (1.47) | 0.24 | (0.56) | — | — | — | — | — | — |
| Revenue per Share | 15.09 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 69.0 | 67.3 | 65.5 | 65.0 | 64.1 | 63.0 | 61.0 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 69.0 | 67.3 | 65.5 | 65.0 | 64.1 | 64.3 | 61.0 | — | — | — | — | — | — |
| Supplemental | |||||||||||||
| EBITDA | — | (172.2) | (84.4) | (219.4) | (80.5) | 34.4 | 1.2 | (11.0) | (39.1) | (56.4) | (72.9) | (64.5) | (71.6) |
| EBIT | (45.8) | (187.3) | (99.1) | (233.2) | (92.8) | 22.7 | (8.0) | (16.7) | (44.6) | (62.9) | (78.1) | (69.0) | (75.7) |
| Effective Tax Rate | -3.8% | — | — | -1.1% | -1.9% | 2.1% | 5.2% | -0.6% | -0.0% | -0.0% | 0.0% | -0.0% | -0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.